113 related articles for article (PubMed ID: 7802663)
1. Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukemia cell lines.
Sakai I; Hashimoto S; Yoda M; Hida T; Ohsawa S; Nakajo S; Nakaya K
Biochem Biophys Res Commun; 1994 Dec; 205(2):1305-10. PubMed ID: 7802663
[TBL] [Abstract][Full Text] [Related]
2. Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers.
Zhang L; Nakaya K; Yoshida T; Kuroiwa Y
Cancer Res; 1992 Sep; 52(17):4634-41. PubMed ID: 1324788
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment of leukemia cells with vitamin K2 and 1alpha,25-dihydroxy vitamin D3 enhances monocytic differentiation along with becoming resistant to apoptosis by induction of cytoplasmic p21CIP1.
Iguchi T; Miyazawa K; Asada M; Gotoh A; Mizutani S; Ohyashiki K
Int J Oncol; 2005 Oct; 27(4):893-900. PubMed ID: 16142303
[TBL] [Abstract][Full Text] [Related]
4. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis.
Kameda T; Miyazawa K; Mori Y; Yuasa T; Shiokawa M; Nakamaru Y; Mano H; Hakeda Y; Kameda A; Kumegawa M
Biochem Biophys Res Commun; 1996 Mar; 220(3):515-9. PubMed ID: 8607797
[TBL] [Abstract][Full Text] [Related]
5. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
Funato K; Miyazawa K; Yaguchi M; Gotoh A; Ohyashiki K
Leukemia; 2002 Aug; 16(8):1519-27. PubMed ID: 12145693
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effect of all-trans retinoic acid.
Yaguchi M; Miyazawa K; Katagiri T; Nishimaki J; Kizaki M; Tohyama K; Toyama K
Leukemia; 1997 Jun; 11(6):779-87. PubMed ID: 9177427
[TBL] [Abstract][Full Text] [Related]
7. Effects of novel uracil analogs on proliferation and differentiation of human myeloid leukemia cells.
Makishima M; Honma Y; Hozumi M; Sampi K; Hattori M; Ishikawa I; Ogura H; Motoyoshi K
Exp Hematol; 1992 Aug; 20(7):879-85. PubMed ID: 1321051
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
[TBL] [Abstract][Full Text] [Related]
9. Vitamin K2 modulates differentiation and apoptosis of both myeloid and erythroid lineages.
Sada E; Abe Y; Ohba R; Tachikawa Y; Nagasawa E; Shiratsuchi M; Takayanagi R
Eur J Haematol; 2010 Dec; 85(6):538-48. PubMed ID: 20887388
[TBL] [Abstract][Full Text] [Related]
10. Geranylgeranylacetone used as an antiulcer agent is a potent inducer of differentiation of various human myeloid leukemia cell lines.
Sakai I; Tanaka T; Osawa S; Hashimoto S; Nakaya K
Biochem Biophys Res Commun; 1993 Mar; 191(3):873-9. PubMed ID: 8466527
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis/differentiation-inducing effects of vitamin K2 on HL-60 cells: dichotomous nature of vitamin K2 in leukemia cells.
Miyazawa K; Yaguchi M; Funato K; Gotoh A; Kawanishi Y; Nishizawa Y; Yuo A; Ohyashiki K
Leukemia; 2001 Jul; 15(7):1111-7. PubMed ID: 11455981
[TBL] [Abstract][Full Text] [Related]
12. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
Chen ZX; Breitman TR
Cancer Res; 1994 Jul; 54(13):3494-9. PubMed ID: 8012972
[TBL] [Abstract][Full Text] [Related]
13. Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines.
Yokoyama T; Miyazawa K; Yoshida T; Ohyashiki K
Int J Oncol; 2005 Jan; 26(1):33-40. PubMed ID: 15586222
[TBL] [Abstract][Full Text] [Related]
14. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
15. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid.
Drach J; Lopez-Berestein G; McQueen T; Andreeff M; Mehta K
Cancer Res; 1993 May; 53(9):2100-4. PubMed ID: 8481912
[TBL] [Abstract][Full Text] [Related]
16. Vitamins K1 and K2 potentiate hyperthermia by down-regulating Hsp72 expression in vitro and in vivo.
Shimohara S; Murakami T; Morikawa M; Matsuo J; Nagayama S; Shuto T; Suico MA; Okiyoneda T; Yamatsu I; Mizushima T; Shimasaki T; Kai H
Int J Oncol; 2005 Dec; 27(6):1527-33. PubMed ID: 16273208
[TBL] [Abstract][Full Text] [Related]
17. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of thrombomodulin antigen levels in U937 cells by combined stimulation with estradiol-17beta and vitamin K2 (menaquinone 4).
Nishiguchi T; Kobayashi T; Sugimura M; Kobayashi H; Terao T
Semin Thromb Hemost; 1999; 25(5):509-17. PubMed ID: 10625211
[TBL] [Abstract][Full Text] [Related]
19. Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells.
Chen Z; Wang W; Pan J; Chen L; Xue Y
Chin Med J (Engl); 1999 Apr; 112(4):352-5. PubMed ID: 11593538
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of proliferation and induction of differentiation of human myeloid leukemia cells by novel nucleoside analogs.
Honma Y; Ikuta T; Kasukabe T; Hozumi M; Itoh T; Ogura H
Anticancer Res; 1988; 8(4):695-9. PubMed ID: 3178159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
